Main Article Content
Objective: to report a case of an incidental large asymptomatic AAA in an ex-smoker with severe COPD successfully treated by EVAR and to delineate the results and complications of EVAR performed in operative theater of Siriraj Hospital.
Methods: A retrospective review of selected high-risk patients with asymptomatic AAA treated by EVAR in operative theater of our hospital from August 2003 to December 2005 was performed.
Results: All nine cases (100%), including reported case (100%), were successfully treated by EVAR. Merely one of 30-day perioperative death (11.1%), of post-operative cardiopulmonary arrest (11.1%), of early AAA rupture (11.1%), of early graft limb occlusion (11.1%), of late graft limb occlusion (11.1%), and of early type II endoleak (11.1%) took place in this study. Neither late AAA rupture, AAA sac enlargement, nor graft migration happened.
Conclusion: EVAR was achieved as a minimal invasive treatment of an incidental large asymptomatic AAA in an ex-smoker with severe COPD. Although EVAR provides an excellent alternative of AAA in high-risk patients, its high peri-operative mortality rate around 10 % should be taken into account.
All articles published in the Siriraj Medical Journal (SMJ) are protected by copyright. No material in this journal may be reproduced on any platform including electronic or in print or transmitted by any means, in whole or in part, without the prior written permission of the Editor of the SMJ. Written permission must also be obtained before any part of the SMJ is stored in any retrieval system of any nature.